MTOR and large cell neuroendocrine carcinoma: Moreover, in this study, PI3K/AKT/mTOR pathway alterations have been identified in LCNEC, in particular PIK3CA mutations (11%), PIK3CA copy number variation (CNV) (33.3%), and RICTOR CNV (37%).